DB

Dr. Chandrakant Bonde

SSR College of Pharmacy Silvassa, NMIMS School of Pharmacy and Technology Management, Rashtrasant Tukadoji Maharaj Nagpur University, Mumbai University

ORCID iD 0000-0001-5712-1119

About

Dr. Chandrakant Bonde is a distinguished pharmaceutical scientist, currently serving as Principal at SSR College of Pharmacy in Silvassa. Holding an M.Pharm, Ph.D., and MBA, he specializes in pharmaceutical and medicinal chemistry, focusing on the design and development of new chemical entities (including anti‑HIV and antitubercular agents), computer‑aided drug design, stability‑indicating LC‑MS methods, analytical and bio‑analytical methods, and impurity synthesis . Throughout his career, Dr. Bonde has contributed extensively to research, with over 75 publications (55 international and 20 national), multiple presentations, funded and consultancy projects, and fellowships such as a BOYSCAST research fellowship from DST and the Most Cited Research Article award from Elsevier . Additionally, he holds the position of President of the UT DNH & DD branch of the Association of Pharmaceutical Teachers of India (APTI) .

Employment

  • SSR College of Pharmacy Silvassa Professor and Principal
    2023 - Present
  • NMIMS School of Pharmacy and Technology Management Professor
    2017 - 2023
  • College of Pharmacy and Health Sciences St Johns University NYC Post-doc (BOYSCAST FELLOW)
    2011 - 2012
  • NMIMS School of Pharmacy and Technology Management: Dhule, Maharashtra, IN Associate Professor
    2007 - 2017

Education

  • Rashtrasant Tukadoji Maharaj Nagpur University Ph.D
    2002 - 2005
  • Mumbai University M.Pharm
    1998 - 2001

Projects & Funding

Projects & funding information is unavailable.

Publications (97)

  • Advances in gelatin-based scaffolds for tissue engineering applications: A review
    Journal of Drug Delivery Science and Technology 2025
    +Save
  • Bioelectric Membrane Potential and Breast Cancer: Advances in Neuroreceptor Pharmacology for Targeted Therapeutic Strategies
    Receptors 2025
    +Save
  • Characterization of Forced Degradation Products of Lobeglitazone Sulfate by Liquid Chromatography--Tandem Mass Spectrometry and In Silico Toxicity Study—Development and Validation of Stability-Indicating Reverse Phase Liquid Chromatographic Method
    Separation Science Plus 2025
    +Save
  • Exploring the potential antidiabetic effects of alkannin (a naphthoquinone compound): in vivo and in silico studies
    Pharmacognosy Magazine 2025
    +Save
  • Green Chemistry: Strategies and Sustainable Approaches for Bridging UN SDGS
    ChemistrySelect 2025
    +Save
  • Investigating the Impact of Acute and 28-days Oral Exposure to Decaprenyl phosphoryl-$β$-D-ribose 2’-epimerase (DprE1) Inhibitors on Vital Organ Function in Swiss Albino Mice
    Indian Journal of Pharmaceutical Education and Research 2025
    +Save
  • Quality by design (QbD) based systematic development of nanobiosystems
    Intelligent Nanobiosystems in Medicine and Healthcare, Volume 1 2025
    +Save
  • Solid core nanoparticles-based nanobiosystems
    Intelligent Nanobiosystems in Medicine and Healthcare, Volume 2 2025
    +Save
  • A comprehensive review on sustainable production of nano crystalline cellulose from sugarcane bagasse and its applications
    Chemical Engineering Communications 2025
    +Save
  • Vitamins as Nutraceuticals for Viral Infection
    Preventive and Therapeutic Role of Vitamins as Nutraceuticals 2024
    +Save